Inactive Instrument

Wintac Limited Share Price

524758

INE812C01016

Wintac Limited is an India-based company, which is engaged in the formulations business. The Company is involved in formulation sales, manufacturing charges and formulation development. Its products are classified under categories, including injectable and ophthalmic. Its ophthalmic product range includes Timolol Maleate Eye Drops, Atropine Eye Drops, Fluorometholone Eye Drops, Olopatadine Eye Drops, Chloramphenicol Eye Drops, Diclofenac Eye Drops, Ketorolac Tromethamine Eye Drops and Bromfenac Eye Drops. Its injectable product range includes Diclofenac Injection, Pheniramine Maleate Injection, Iron Sucrose Injection, Pentoxifylline Injection, Atropine Injection, Hyoscine Butyl Bromide Injection, Ondansetron Injection, Metoclopramide Injection, Tramadol Injection, Analgin Injection, Gentamicin Sulphate Injection and Levofloxacin Injection. The Company carries out formulation development activities in the export market, including the United States, Canada, Australia and Europe.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
524758 Stock

Google lets you customize your preferred sources.

Choose MarketScreener

09/08/23	Somerset Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI
10/08/22	Wintac Limited Reports Earnings Results for the Full Year Ended March 31, 2022	CI
12/11/20	Wintac Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	CI
07/08/20	Wintac Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	CI
22/06/20	Wintac Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	CI
04/02/20	Wintac Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	CI
04/02/20	Wintac Limited Appoints S. Nanthitha as Additional Director	CI
27/01/20	Wintac Limited Announces Resignation of Ms. K. M. Ganga as Independent Director	CI
13/11/19	Wintac Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	CI
12/08/19	Wintac Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	CI
23/05/19	Wintac Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	CI
26/02/19	Par Formulations Pvt Ltd cancelled the acquisition of Pharmaceutical Business from Wintac Limited.	CI
11/02/19	Wintac Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2018	CI

Manager	Title	Age	Since
Sudhakar Varamballi Krupendra DFI	Director of Finance/CFO	-	31/01/2015
Velusamy Jaiashokan COO	Chief Operating Officer	-	31/12/2021
Karupannan Poongudi Murali PRN	Corporate Officer/Principal	-	31/12/2020

Director	Title	Age	Since
R. A. Thirumoorti BRD	Director/Board Member	53	10/07/2013
K. Paranjothy CHM	Chairman	78	-
Karupannan Poongudi Murali BRD	Director/Board Member	-	31/12/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WINTAC LIMITED	+0.31%	+0.47%	-	-	46.59M
ELI LILLY AND COMPANY	-1.14%	-2.43%	+53.72%	+159.07%	1,070B
JOHNSON & JOHNSON	-1.41%	+0.32%	+66.23%	+60.48%	624B
ABBVIE INC.	-2.42%	+0.18%	+34.59%	+85.62%	450B
ROCHE HOLDING AG	-0.92%	+0.53%	+31.00%	+25.82%	328B
ASTRAZENECA PLC	+0.91%	+0.70%	+38.95%	+40.44%	292B
NOVARTIS AG	+0.42%	-0.87%	+28.55%	+47.78%	284B
NOVO NORDISK A/S	+2.16%	+4.31%	-25.62%	-38.89%	217B
AMGEN INC.	-2.06%	+1.63%	+22.87%	+64.34%	198B
GILEAD SCIENCES, INC.	-1.26%	+2.60%	+15.98%	+70.00%	161B
Average	+0.27%	+1.07%	+29.59%	+57.18%	402.71B
Weighted average by Cap.	+0.66%	+0.77%	+40.17%	+81.65%

Wintac Limited Share Price

Stocks

524758

INE812C01016

Pharmaceuticals

Latest news : Wintac Limited

Press Releases: Wintac Limited

Quotes and Performance

Managers and Directors: Wintac Limited

Other Pharmaceuticals

Company Profile